We are please to provide the following community statement that has just been released by Ionis about their upcoming clinical trial.
Ionis prion community update - October 2023 - finalJohn Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology.
In Conversation with… John Collinge (link to podcast with listing options)